Quotes 5-day view Delayed Nyse
Estimated financial data (e) (USD)
Net income 2019
Net Debt 2019
P/E ratio 2019
Net income 2020
Net cash position 2020
P/E ratio 2020
EV / Sales 2019
EV / Sales 2020
Nbr of Employees
Rafael Holdings, Inc. is a clinical-stage oncology pharmaceutical company. The Company is focused on developing and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. It also owns interests in certain commercial real estate assets. The Company conducts business as two operating segments, Pharmaceuticals and Real Estate.
All news about RAFAEL HOLDINGS, INC.
08:01a Rafael Pharmaceuticals Announces APOLLO613 Phase I/II Clinical Trial of CPI-613« (devim..
09/24 RAFAEL : Names Ashok Marin Chief Legal Officer
09/24 RAFAEL : Continues to Expand its Management Team with a Highly Experienced Global Biopharm..
09/24 Rafael Holdings, Inc. Appoints Ashok Marin as Chief Legal Officer
09/24 RAFAEL : President Steps Down
09/24 RAFAEL : Management Change/Compensation (Form 8-K)
09/24 RAFAEL HOLDINGS, INC. : Change in Directors or Principal Officers (form 8-K)
09/24 Menachem Ash Voluntarily Resigns as President and General Counsel of Rafael Holdings, I..
09/17 RAFAEL : Announces Inducement Grant Under NYSE Rule 303A.08
09/14 RAFAEL : Names Patrick Fabbio Finance Chief
09/14 RAFAEL : Appoints Patrick Fabbio as Chief Financial Officer (Form 8-K)
09/14 RAFAEL HOLDINGS, INC. : Change in Directors or Principal Officers, Financial Statements an..
09/14 RAFAEL : Appoints Patrick Fabbio as Chief Financial Officer
09/14 Rafael Holdings, Inc. Appoints Patrick Fabbio as Chief Financial Officer
09/11 INVESTIGATION : Halper Sadeh LLP Investigates GTS, RFL, NLOK, MDLA, STMP, GPX; Shareholder..
News in other languages on RAFAEL HOLDINGS, INC.
Chart RAFAEL HOLDINGS, INC.
Technical analysis trends RAFAEL HOLDINGS, INC.
Short Term Mid-Term Long Term Trends Bearish Bearish Bullish